Skip to content
Safety ProfileEvidence-Based

5-Amino-1MQ Side Effects

Honest, evidence-based safety analysis for 5-Amino-1MQ. Frequency data, severity classification, data limitations, and what we genuinely don't know.

Quick Answer

Common side effects include mild gastrointestinal discomfort and headache. Serious risks involve potential disruption of methylation pathways and an unknown long-term safety profile. As of 2026, no published human clinical trials exist. Be cautious about methylation changes, as they influence many biological processes.

→ 5-Amino-1MQ Dosage→ 5-Amino-1MQ Benefits→ Full 5-Amino-1MQ Profile
Table of Contents

Data Context: What We Actually Know

Important: data limitations

Side effect data is based on user reports and theoretical concerns. No clinical trials have assessed the safety profile of 5-Amino-1MQ in humans. The information below should be regarded as preliminary. This compound should be used with caution.

Side Effects by Severity

MildModerateSevere / Serious
Gastrointestinal discomfortMild

Frequency: Common

Nausea, bloating, or stomach upset may occur, typically in the first few weeks. Starting with a low dose can minimize this.

HeadacheMild

Frequency: Common

Headache may be reported, especially during the initial dosing period. Usually, resolves within a few days.

Fatigue or lethargyMild

Frequency: Rare

May occur during the initial days of use. Usually, resolves as the body adapts.

Disruption of methylation pathwaysSevere / Serious

Frequency: Unknown

NNMT inhibition alters SAM/SAH ratios, potentially affecting DNA methylation. Monitor for associated issues.

Unknown long-term safetySevere / Serious

Frequency: Unknown

Lack of human clinical data makes the long-term safety profile unknown. Exercise considerable caution during use.

Contraindications

  • ✕Pregnancy and breastfeeding (no safety data)
  • ✕Individuals with methylation disorders or related sensitivities
  • ✕Known hypersensitivity to quinolinium compounds
  • ✕Those with compromised liver or kidney function

Drug Interactions

No formal pharmacokinetic drug interaction studies have been conducted for most research peptides. The interactions below are theoretical, mechanism-based, or derived from limited case reports.
  • ⚠Methylation-dependent medications: May interfere with the effectiveness of drugs relying on methylation pathways
  • ⚠NAD+ precursors: Concurrent use may have additive effects on NAD+ levels (clinical significance unknown)
  • ⚠SAMe (S-Adenosylmethionine): Potential interaction due to involvement in methylation pathways
  • ⚠No formal drug interaction studies have been conducted in humans

Frequently Asked Questions

How safe is 5-Amino-1MQ?
There is limited safety information available for 5-Amino-1MQ. Side effect data is from self-reports and theory. Long-term safety is unknown. Use with extreme caution, and consider the risks before using.
What are the possible side effects of 5-Amino-1MQ?
Reported side effects include gastrointestinal discomfort, headache, fatigue. A serious theoretical risk is disruption of methylation pathways. The long-term effects of NNMT inhibition in humans are unknown.
Who should avoid 5-Amino-1MQ?
Avoid using 5-Amino-1MQ if pregnant or breastfeeding, if you have methylation disorders, or if you have a known sensitivity to quinolinium compounds. Use caution with compromised liver or kidney function.
Does 5-Amino-1MQ interact with other medications?
There is no formal study of drug interactions. Be cautious if taking medications affected by methylation. Concomitant use with NAD+ precursors or SAMe should be approached with caution.
Can 5-Amino-1MQ affect my mood or cognitive function?
Although not commonly reported, changes in methylation pathways could potentially affect mood and cognitive function. Monitor for any changes in mood, focus, or mental clarity, and discontinue use if needed.

References

  1. 1
    Nicotinamide N-methyltransferase: an emerging protagonist in cancer and metabolic disease(2017)PubMed ↗
  2. 2
    The role of nicotinamide N-methyltransferase in metabolic regulation(2014)PubMed ↗
  3. 3
    NNMT inhibition effectively activates NAD+ salvage pathway in adipocytes and prevents diet-induced obesity(2020)PubMed ↗

Last updated: 2026-02-19